[
  {
    "query_id": "0xc4e3d8e3c3df486bb17b7eaf4347008697863dfb7541b78c8594bb22f1fcf96e",
    "transaction_hash": "0x8a7e243115d69383d95e199a8c56d733117c14e64a71a45a3e9c82511169a0e4",
    "block_number": 72568778,
    "request_transaction_block_time": 1749500515,
    "ancillary_data": "q: title: FDA approves Merck's clesrovimab infant RSV prevention (MK\u00e2\u0080\u00911654)?, description: This market will resolve to \"Yes\" if the U.S. Food and Drug Administration (FDA) grants full or conditional approval for Merck's biologics license application (BLA) for clesrovimab (MK\u00e2\u0080\u00911654) as a preventive treatment for respiratory syncytial virus (RSV) in infants by June 17, 2025, 11:59 PM ET. Otherwise, this market will resolve to \"No\".\n\nThis market will immediately resolve to \"No\" if the FDA issues a Complete Response Letter (CRL), explicitly declines to approve the application. \n\nConditional approvals may include post-marketing requirements or commitments and still qualify.\n\nThe primary resolution source will be official information from the FDA, however a consensus of credible reporting may also be used. \n market_id: 550768",
    "ancillary_data_hex": "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",
    "resolution_conditions": "res_data:p1: 0, p2: 1, p3: 0.5. Where p1 corresponds to No, p2 to Yes, p3 to unknown/50-50.",
    "proposed_price": 1000000000000000000,
    "proposed_price_outcome": "p2",
    "resolved_price": null,
    "resolved_price_outcome": null,
    "request_timestamp": 1749410223,
    "expiration_timestamp": 1749507715,
    "creator": "0x6A9D222616C90FcA5754cd1333cFD9b7fb6a4F74",
    "proposer": "0x1eDE6d863Ae28992C9087Ad38b1176a34f107adE",
    "bond_currency": "0x2791Bca1f2de4661ED88A30C99A7a9449Aa84174",
    "proposal_bond": 500000000,
    "reward_amount": 5000000,
    "updates": [],
    "condition_id": "0x108e7a674ae7c86ff698b50833e2c8ee8d02bc336cc3ca1a2c42bc348cbbc738",
    "tags": [
      "Science",
      "Tech",
      "drug"
    ],
    "icon": "https://polymarket-upload.s3.us-east-2.amazonaws.com/fda-approves-mercks-clesrovimab-infant-rsv-prevention-mk1654-UwIlSPqRRYN3.jpg",
    "end_date_iso": "2025-06-17T00:00:00Z",
    "game_start_time": null,
    "tokens": [
      {
        "token_id": "110277767978162820657507122560579831140491170286088857058778075751412428867594",
        "outcome": "Yes",
        "price": 1,
        "winner": true
      },
      {
        "token_id": "70799734104664715408631734640682620690445973392429122858338693410839545371422",
        "outcome": "No",
        "price": 0,
        "winner": false
      }
    ],
    "neg_risk_market_id": "",
    "neg_risk_request_id": ""
  }
]